Mohammed Bourdi
Impact in
- Pharmacology top 0.1%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
- Hepatology top 1%
- Liver physiology and pathology
- Liver Disease and Transplantation
- Liver Diseases and Immunity
Papers in
- Pharmacology 26
- Drug-Induced Hepatotoxicity and Protection 23
- Pharmacogenetics and Drug Metabolism 7
- Inflammatory mediators and NSAID effects 3
- Hepatology 10
- Liver physiology and pathology 4
- Co-authors
- Lance R. Pohl (26 shared papers)Timothy P. Reilly (10 shared papers)John W. George (8 shared papers)Jackie L. Martin (8 shared papers)John Brady (5 shared papers)Michael F. Radonovich (5 shared papers)Philippe Beaune (6 shared papers)Yasuhiro Masubuchi (2 shared papers)
- Journals
- Chemical Research in Toxicology (10 papers)Biochemical and Biophysical Research Communications (6 papers)Hepatology (4 papers)Regulatory Toxicology and Pharmacology (3 papers)Molecular Pharmacology (2 papers)
- Partner nations
- United StatesFranceBelgium
In The Last Decade
Mohammed Bourdi
38 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 107
- Pharmacology 1.5k
- Hepatology 696
- Oncology 435
- Epidemiology 465
- Biochemistry 108
Countries citing papers authored by Mohammed Bourdi
This map shows the geographic impact of Mohammed Bourdi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammed Bourdi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammed Bourdi more than expected).
Fields of papers citing papers by Mohammed Bourdi
This network shows the impact of papers produced by Mohammed Bourdi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammed Bourdi. The network helps show where Mohammed Bourdi may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammed Bourdi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 314 | |
| 2 | 2002 | 261 | |
| 3 | 1990 | 171 | |
| 4 | 1996 | 160 | |
| 5 | 2001 | 127 | |
| 6 | 2003 | 125 | |
| 7 | 2001 | 90 | |
| 8 | 1995 | 88 | |
| 9 | 2011 | 79 | |
| 10 | 1994 | 76 | |
| 11 | 2002 | 73 | |
| 12 | 2011 | 70 | |
| 13 | 1997 | 69 | |
| 14 | 2007 | 69 | |
| 15 | 1992 | 68 | |
| 16 | 2016 | 62 | |
| 17 | 2007 | 56 | |
| 18 | 2015 | 54 | |
| 19 | 2009 | 52 | |
| 20 | 2002 | 49 |
About Mohammed Bourdi
Mohammed Bourdi is a scholar working on Pharmacology, Hepatology, Oncology, Epidemiology and Molecular Biology, having authored 38 papers that have together received 2.5k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (23 papers), Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (6 papers), Liver physiology and pathology (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Endoplasmic Reticulum Stress and Disease (3 papers), Inflammatory mediators and NSAID effects (3 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Pharmacology (1.5k citations), Hepatology (696 citations), Oncology (435 citations), Epidemiology (465 citations) and Biochemistry (108 citations). Mohammed Bourdi has collaborated with scholars based in United States, France and Belgium. Frequent co-authors include Lance R. Pohl, Timothy P. Reilly, John W. George, Jackie L. Martin, John Brady, Michael F. Radonovich, Philippe Beaune, Yasuhiro Masubuchi, Cynthia Ju and Hamid Amouzadeh. Their work appears in journals such as Chemical Research in Toxicology, Biochemical and Biophysical Research Communications, Hepatology, Regulatory Toxicology and Pharmacology and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.